
A Q&A with the Population Health Lab
July 2, 2025
Our team’s research and policy recommendations on prescription drug benefit design will help 3.5 million beneficiaries and millions of more in the future through changes embedded in the Inflation Reduction Act.
Amol’s expertise is in policy analysis and design, physician and hospital economic behavior, and application of informatics and predictive analytics to health care.
Since 2008, CHIBE has developed and tested scalable and cost-effective interventions that have improved the health of tens of millions of individuals. We’ve worked with a variety of groups, including health systems, clinicians, communities, individuals, NGOs, consumer companies, governments, and health insurers.